Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $12.00
Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) had its price target upped by Scotiabank from $10.00 to $12.00 in a research report released on Thursday,Benzinga reports. They currently have a sector outperform rating on the stock. A number of other equities analysts also recently weighed in on the company. The Goldman Sachs Group boosted their target […]
Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) had its price target upped by Scotiabank from $10.00 to $12.00 in a research report released on Thursday,Benzinga reports. They currently have a sector outperform rating on the stock. A number of other equities analysts also recently weighed in on the company. The Goldman Sachs Group boosted their target […]
